Affimed

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Affimed and other ETFs, options, and stocks.

About AFMD

Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs.

CEO

Andreas Harstrick

CEOAndreas Harstrick

Employees

Employees78

Headquarters

Mannheim, Baden Wuerttemberg

HeadquartersMannheim, Baden Wuerttemberg

Founded

2000

Founded2000

Employees

Employees78

AFMD Key Statistics

Market cap

76.14M

Market cap76.14M

Price-Earnings ratio

-2.42

Price-Earnings ratio-2.42

Dividend yield

—

Dividend yield—

Average volume

74.91K

Average volume74.91K

High today

$5.25

High today$5.25

Low today

$4.72

Low today$4.72

Open price

$5.07

Open price$5.07

Volume

95.76K

Volume95.76K

52 Week high

$11.10

52 Week high$11.10

52 Week low

$2.24

52 Week low$2.24

AFMD News

Yahoo Finance 6d

Affimed N.V. Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - Yahoo Finance

A downtrend has been apparent in Affimed N.V. (AFMD) lately. While the stock has lost 12% over the past week, it could witness a trend reversal as a hammer char...

Analyst ratings

86%

of 7 ratings

Buy

85.7%

Hold

14.3%

Sell